ABK Biomedical
- Business Model
- B2B
- Website
- abkbiomedical.com
- Total Funding
- $104.0M
- Last Round
- $35.0M Series DOct 2025
- Rounds
- 5
About
Clinical-stage medical device company developing imageable embolic therapies to treat liver tumors.
Summary
ABK Biomedical is a Healthcare company. It has raised $104.0M in total across 5 rounds, most recently a $35.0M Series D round in Oct 2025. Investors include F-Prime Capital, J.P. Morgan Life Sciences Private Capital and Sante Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...